This article was originally published in The Gray Sheet
Dublin, Ireland-based firm receives FDA go-ahead to market the Uni-Gold H. pylori one step test, the company announces Jan. 5. Requiring only one drop of whole blood, serum or plasma, the test screens for the presence of IgG antibodies to the bacterium, which is believed to be the causative agent in over 90% of duodenal ulcers, 70% of gastric ulcers and 60% of gastric cancers
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.